Licensed Practical Nurse in Onamia, MN Accepting Medicare

5 Licensed Practical Nurse nurses found. Showing 1 - 5

Ms. Cindy Lou Delaney, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Elm St N, Onamia, MN 56359 Phone: 320-532-3154    Fax: 320-532-3111

Miss Angela Kray, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17230 Noopiming Dr, Onamia, MN 56359 Phone: 320-532-7783    Fax: 320-532-7524

Kim Jo Leschak, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17230 Noopiming Dr, Onamia, MN 56359 Phone: 320-532-7776    Fax: 320-532-7524

Denise Kulhanek, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17230 Noopiming Dr, Onamia, MN 56359 Phone: 320-532-7776    Fax: 320-532-7524

Lola Marie Austin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17230 Noopiming Dr, Onamia, MN 56359 Phone: 320-532-7776    Fax: 320-532-7524

News Archive

AllerAir supports global awareness campaign on Multiple Chemical Sensitivity Syndrome

This May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury Associations worldwide in their effort to spread Multiple Chemical Sensitivity Syndrome awareness

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

A study among almost 50,000 people worldwide has identified DNA sequence variations linked with the heart's electrical rhythm in several surprising regions among 22 locations across the human genome. The variants were found by an international consortium, including Johns Hopkins researchers, and reported Nov. 14 in the Nature Genetics advance online publication.

TopBP1 protein prevents early brain cells from DNA damage

St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.

World's third rectal microbicide trial launched in Pittsburgh

The world's third rectal microbicide trial launched in Pittsburgh, Pennsylvania today, with sites preparing to open in Boston, Massachusetts, and Birmingham, Alabama soon. Scientists will test the rectal safety and acceptability of tenofovir gel, a microbicide developed for vaginal use that has shown promise for preventing HIV through vaginal intercourse. Depending on the outcome of this new study, tenofovir gel could be further evaluated to determine if it can reduce the risk of HIV among both men and women who engage in receptive anal intercourse.

Read more Medical News

› Verified 4 days ago